USANA Health Sciences, Inc. (NYSE:USNA) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Wednesday.

Separately, Pivotal Research reduced their price objective on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research report on Wednesday, July 26th.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.06 by ($0.08). USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The business had revenue of $257.10 million during the quarter, compared to the consensus estimate of $273.61 million. During the same period in the prior year, the company posted $2.07 earnings per share. The firm’s revenue was down .5% compared to the same quarter last year.

USANA Health Sciences declared that its Board of Directors has initiated a share buyback plan on Tuesday, July 25th that authorizes the company to buyback $64.60 million in shares. This buyback authorization authorizes the company to repurchase up to 46% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “BidaskClub Upgrades USANA Health Sciences, Inc. (USNA) to Sell” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/10/13/bidaskclub-upgrades-usana-health-sciences-inc-usna-to-sell.html.

In other USANA Health Sciences news, COO Jim Brown sold 16,574 shares of USANA Health Sciences stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $58.84, for a total transaction of $975,214.16. Following the completion of the transaction, the chief operating officer now directly owns 2,175 shares of the company’s stock, valued at $127,977. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Myron W. Wentz sold 40,000 shares of USANA Health Sciences stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $56.59, for a total value of $2,263,600.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 386,340 shares of company stock valued at $22,270,913. Company insiders own 53.20% of the company’s stock.

Several large investors have recently made changes to their positions in USNA. Russell Investments Group Ltd. increased its stake in shares of USANA Health Sciences by 11.8% in the first quarter. Russell Investments Group Ltd. now owns 27,619 shares of the company’s stock valued at $1,591,000 after buying an additional 2,926 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of USANA Health Sciences by 70.8% in the first quarter. Wells Fargo & Company MN now owns 31,480 shares of the company’s stock valued at $1,814,000 after buying an additional 13,044 shares in the last quarter. First Trust Advisors LP increased its stake in shares of USANA Health Sciences by 104.3% in the first quarter. First Trust Advisors LP now owns 25,069 shares of the company’s stock valued at $1,444,000 after buying an additional 12,800 shares in the last quarter. Karp Capital Management Corp acquired a new stake in shares of USANA Health Sciences in the first quarter valued at $595,000. Finally, Ameriprise Financial Inc. increased its stake in shares of USANA Health Sciences by 19.6% in the first quarter. Ameriprise Financial Inc. now owns 44,563 shares of the company’s stock valued at $2,567,000 after buying an additional 7,305 shares in the last quarter. Institutional investors own 44.85% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.